|
|
Welcome to Medical Oncology Research Labs
The mission of the Department of Medical Oncology at Dana-Farber Cancer Institute is to provide outstanding and
compassionate clinical care to patients with cancer, to perform cutting-edge basic and clinical research, and to
provide education and training to the next generation of physicians and scientists who are focused on the biology and treatment of cancer. The department provides a structure in which basic scientists, clinical and translational investigators, and clinical oncologists interact, collaborate, and pool their collective expertise to make significant advances in cancer care and research.
The Department of Medical Oncology oversees more than 80 independent laboratories, with wide-ranging interests related to cancer biology in an extraordinary intellectual and scientific environment. Investigators are highly collaborative, both within Dana-Farber and in the broader Harvard/MIT community, and are supported through a range of cores, internal grant opportunities, and philanthropy. Faculty within Medical Oncology have played central roles in some of the revolutionary findings of recent years, including the identification and characterization of immune checkpoints, identification of the genetic drivers of a wide range of malignancies, the development and application of functional genomics, and the application of large datasets and the tools of population sciences to cancer research. The department has a growing team of individuals with deep expertise in computational biology and data sciences which allows DFCI to leverage complex data derived from genomics and genetics, population data, and epidemiologic data, synthesizing the information for a better understanding of dynamic networks on a variety of levels.
A defining feature of the Department of Medical Oncology is the integration of outstanding basic cancer research and clinical oncology within the same department. Nearly all basic scientists in the department are clinically trained and are motivated to link the implications of laboratory findings to potential clinical impact, and to take clinical observations as the inspiration for laboratory studies.
compassionate clinical care to patients with cancer, to perform cutting-edge basic and clinical research, and to
provide education and training to the next generation of physicians and scientists who are focused on the biology and treatment of cancer. The department provides a structure in which basic scientists, clinical and translational investigators, and clinical oncologists interact, collaborate, and pool their collective expertise to make significant advances in cancer care and research.
The Department of Medical Oncology oversees more than 80 independent laboratories, with wide-ranging interests related to cancer biology in an extraordinary intellectual and scientific environment. Investigators are highly collaborative, both within Dana-Farber and in the broader Harvard/MIT community, and are supported through a range of cores, internal grant opportunities, and philanthropy. Faculty within Medical Oncology have played central roles in some of the revolutionary findings of recent years, including the identification and characterization of immune checkpoints, identification of the genetic drivers of a wide range of malignancies, the development and application of functional genomics, and the application of large datasets and the tools of population sciences to cancer research. The department has a growing team of individuals with deep expertise in computational biology and data sciences which allows DFCI to leverage complex data derived from genomics and genetics, population data, and epidemiologic data, synthesizing the information for a better understanding of dynamic networks on a variety of levels.
A defining feature of the Department of Medical Oncology is the integration of outstanding basic cancer research and clinical oncology within the same department. Nearly all basic scientists in the department are clinically trained and are motivated to link the implications of laboratory findings to potential clinical impact, and to take clinical observations as the inspiration for laboratory studies.
